Leaderboard

En | De
Sie sind hier: Neurologie » Multiple Sklerose 11. Juli 2020
Suchen
medline.ch
Multiple Sklerose
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Alzheimer
Epilepsie
Infektionen
Kopfschmerzen
Multiple Sklerose
Neoplasie
Neuromuskuläre Erkrankungen
Parkinson
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Anderes
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1508  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 30148  
   
Two-armed active comparator trials are unethical in pediatric multiple sclerosis - No.
Mult Scler
Geraldes R.
PMID: 32648832 [PubMed - as supplied by publisher]


Two-armed active comparator trials are unethical in paediatric multiple sclerosis - Commentary.
Mult Scler
Waubant E.
PMID: 32648815 [PubMed - as supplied by publisher]


Two-armed active comparator trials are unethical in pediatric multiple sclerosis - Yes.
Mult Scler
Krupp LB, Charvet LE.
PMID: 32648814 [PubMed - as supplied by publisher]


COVID-19 outcomes in MS: Observational study of early experience from NYU Multiple Sclerosis Comprehensive Care Center.
Neurol Neuroimmunol Neuroinflamm
Parrotta E, Kister I, Charvet L, Sammarco C, Saha V, Charlson RE, Howard J, Gutman JM, Gottesman M, Abou-Fayssal N, Wolintz R, Keilson M, Fernandez-Carbonell C, Krupp LB, Zhovtis Ryerson L.
PMID: 32646885 [PubMed - in process]


The ocrelizumab phase II extension trial suggests the potential to improve the risk: Benefit balance in multiple sclerosis.
Mult Scler Relat Disord
Baker D, Pryce G, James LK, Marta M, Schmierer K.
PMID: 32645640 [PubMed - as supplied by publisher]


Effectiveness of blood flow-restricted slow walking on mobility in severe multiple sclerosis: a pilot randomized trial.
Scand J Med Sci Sports
Lamberti N, Straudi S, Donadi M, Tanaka H, Basaglia N, Manfredini F.
PMID: 32645227 [PubMed - as supplied by publisher]


Relapses in multiple sclerosis reported by patients versus physicians - Insights from a large observational study.
Eur J Neurol
Schriefer D, Haase R, Ettle B, Ziemssen T.
PMID: 32643851 [PubMed - as supplied by publisher]


AI in Radiology: Where are we today in Multiple Sclerosis Imaging?
Rofo
Eichinger P, Zimmer C, Wiestler B.
PMID: 32643769 [PubMed - as supplied by publisher]


Occupational therapy interventions for multiple sclerosis: A scoping review.
Scand J Occup Ther
Quinn É, Hynes SM.
PMID: 32643486 [PubMed - as supplied by publisher]


Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis.
Ther Adv Neurol Disord
Lycke J, Lenhoff S.
PMID: 32636931 [PubMed]


Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study.
Neurology
Buron MD, Chalmer TA, Sellebjerg F, Barzinji I, Christensen JR, Christensen MK, Hansen V, Illes Z, Jensen HB, Kant M, Papp V, Petersen T, Rasmussen PV, Schäfer J, Theódórsdóttir Á, Weglewski A, Sorensen PS, Magyari M.
PMID: 32636328 [PubMed - as supplied by publisher]


Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study.
Mult Scler
Chitnis T, Banwell B, Krupp L, Arnold DL, Bar-Or A, Brück W, Giovannoni G, Greenberg B, Ghezzi A, Waubant E, Rostasy K, Deiva K, Huppke P, Wolinsky JS, Zhang Y, Azmon A, K-Laflamme A, Karan R, Gärtner J.
PMID: 32633694 [PubMed - as supplied by publisher]


Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigue.
Mult Scler
Fitzgerald KC, Morris B, Soroosh A, Balshi A, Maher D, Kaplin A, Nourbakhsh B.
PMID: 32633662 [PubMed - as supplied by publisher]


Protecting people with multiple sclerosis through vaccination.
Pract Neurol
Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, Cores C, Mathews J, Lambourne J, Marta M, Turner B, Gnanapavan S, Dobson R, Schmierer K, Giovannoni G.
PMID: 32632038 [PubMed - as supplied by publisher]


Impairment in oral medical comprehension in multiple sclerosis.
Rev Neurol (Paris)
Ehrlé N, Moulin M, Richard O, Bonny F, Grosmaire M, Bakchine S.
PMID: 32631677 [PubMed - as supplied by publisher]


Factors associated with relapses in relapsing-remitting multiple sclerosis: A systematic review and meta-analysis.
Medicine (Baltimore)
Xie Y, Tian Z, Han F, Liang S, Gao Y, Wu D.
PMID: 32629678 [PubMed - in process]


Fall definitions, faller classifications and outcomes used in falls research among people with multiple sclerosis: a systematic review.
Disabil Rehabil
O'Malley N, Clifford AM, Comber L, Coote S.
PMID: 32628889 [PubMed - as supplied by publisher]


Toxoplasma gondii infection and multiple sclerosis: An age- and a gender-matched case-control seroprevalence study.
Eur J Microbiol Immunol (Bp)
Méndez-Hernández EM, Hernández-Tinoco J, Salas-Pacheco JM, Sánchez-Anguiano LF, Arias-Carrión O, Sandoval-Carrillo AA, Castellanos-Juárez FX, Ruano-Calderón LÁ, Alvarado-Esquivel C.
PMID: 32628617 [PubMed - as supplied by publisher]


Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.
Front Neurol
Kuchling J, Paul F.
PMID: 32625158 [PubMed]


Prevalence of Anti-JC Virus Antibody Seropositivity in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Intervirology
Hanaei S, Sahraian MA, Mohammadifar M, Ramagopalan SV, Ghajarzadeh M, Ghajarzadeh M.
PMID: 32623436 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 30148    Seite 1 von 1508  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1